Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.59 |
| ▸ | CA1 | P00915 | 7/20 | 0.59 |
| ▸ | CA9 | Q16790 | 6/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.59 |
| ▸ | CA3 | P07451 | 3/20 | 0.59 |
| ▸ | CA4 | P22748 | 3/20 | 0.59 |
| ▸ | CA6 | P23280 | 3/20 | 0.59 |
| ▸ | CA5A | P35218 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | MMP9 | P14780 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | MMP13 | P45452 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29280214 | 0.90 | CA2 (0.53) | CA2CA1CA9CA12CA14 | |
| SCHEMBL29488753 | 0.86 | CA2 (0.59) | CA2CA1CA9CA12CA14 | |
| SCHEMBL28570939 | 0.83 | CA2 (0.47) | CA2CA1CA9CA12CA14 | |
| SCHEMBL29392071 | 0.83 | CA2 (0.55) | CA2CA1CA9CA12CA14 | |
| SCHEMBL29657456 | 0.83 | CA2 (0.55) | CA2CA1CA9CA12CA14 | |
| SCHEMBL29965676 | 0.83 | CA2 (0.55) | CA2CA1CA9CA12CA14 | |
| SCHEMBL468315 | 0.83 | CA1 (0.55) | CA2CA1CA9CA12CA14 | |
| SCHEMBL1964478 | 0.83 | CA2 (0.55) | CA2CA1CA9CA12CA14 | |
| SCHEMBL30185020 | 0.83 | CA1 (0.55) | CA2CA1CA9CA12CA14 | |
| SCHEMBL1759354 | 0.83 | CA2 (0.55) | CA2CA1CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865932-B | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-119684197-A | Preparation of 1, 8-diamino-3, 6-dioxaoctane difunctional derivative | 上海药坦药物研究开发有限公司 | 2025-03-25 | — | — | CN | claimed |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | WUYAN PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD (CN) | 2024-11-07 | — | — | US | claimed |
| CN-117865932-A | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | 北京化工大学 | 2024-04-12 | — | — | CN | claimed |
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-116942890-A | Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof | 西南交通大学 | 2023-10-27 | — | — | CN | claimed |
| CN-115650827-A | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| US-20120157683-A1 | PROCESS FOR THE PREPARATION OF DUTASTERIDE | AUROBINDO PHARMA LTD (IN) | 2012-06-21 | — | — | US | claimed |
| WO-2011004242-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF DUTASTERIDE | AUROBINDO PHARMA LIMITED (IN) | 2011-01-13 | — | — | WO | claimed |
| CN-101429156-A | Novel methods for producing 1,2,3,4-tetrahydrochysene-4,4-dimethyl quinoline and its derivant | HEBEI BAILINGWEI HYPERFINE MAT (CN) | 2009-05-13 | — | — | CN | claimed |
| US-4383946-A | Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals | MERCK & CO., INC. (US) | 1983-05-17 | — | — | US | claimed |
| CN-117865932-B | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-12172956-B2 | Method for the isomerization of a 3-(Z)-unsaturated carboxylic acid to the 3-(E)-isomer | BASF SE (DE) | 2024-12-24 | — | — | US | disclosed |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | WUYAN PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD (CN) | 2024-11-07 | — | — | US | disclosed |
| CN-118696033-A | 1,2, 3-Triazole carbonyl sulfonamide compound and application thereof | PI工业有限公司 | 2024-09-24 | — | — | CN | disclosed |
| EP-0026817-A1 | Preparation of azetidin-2-ones suitable for the synthesis of thienamycin and azetidin-2-ones useful in a synthesis of that kind | MERCK & CO. INC. (US) | 1981-04-15 | — | — | EP | disclosed |
| EP-0026816-A1 | Intermediates for the preparation of thienamycin and process for preparing intermediates | MERCK & CO. INC. (US) | 1981-04-15 | — | — | EP | disclosed |
| US-4262010-A | THIENAMYCIN-RELATED ANTIBIOTICS | MERCK & CO., INC. (US) | 1981-04-14 | — | — | US | disclosed |
| EP-0007973-A1 | Process for the preparation of thienamycin and intermediates | MERCK & CO. INC. (US) | 1980-02-20 | — | — | EP | disclosed |
| US-4115058-A | BLEACHES, DETERGENTS | FMC CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | ANTXR2, AKR7A2, ACR | CA2 411/4885CA1 277/4885CA9 191/4885 |
| US-12172956-B2 | Method for the isomerization of a 3-(Z)-unsaturated carboxylic acid to the 3-(E)-isomer | HCAR2, HCAR1, AKR1C3 | CA2 369/4885CA1 238/4885CA9 884/4885 |
| US-20120157683-A1 | PROCESS FOR THE PREPARATION OF DUTASTERIDE | CYP21A2, CYP17A1, HSD17B7 | CA2 379/4885CA1 525/4885CA9 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.